0 Datasets
0 Files
Get instant academic access to this publication’s datasets.
Join our academic network to download verified datasets and collaborate with researchers worldwide.
Get Free AccessThe early literature on susceptibility to SARS-CoV-2/COVID-19 for people with cancer is characterised by pervasive biases and limited data. To provide high-quality evidence to inform decision-making, studies of risk of SARS-CoV-2/COVID-19 for people with cancer should control for other potential modifiers of infection risk, including age, sex, comorbidities, exposure to the virus, protective measures taken, and vaccination, in addition to stratifying analyses by cancer type, stage at diagnosis, and treatment received.
Chelsea Carle, Suzanne Hughes, Victoria Freeman, Denise Campbell, Sam Egger, Michael Caruana, Harriet Hui, Sarsha Yap, Silvia Deandrea, Tonia C. Onyeka, Maarten J. IJzerman, Ophira Ginsburg, Freddie Ian Bray, Richard Sullivan, Ajay Aggarwal, Stuart Peacock, Kelvin Chan, Timothy P. Hanna, Isabelle Soerjomataram, Dianne L. O’Connell, Karen Canfell, Julia Steinberg (2022). The risk of contracting SARS-CoV-2 or developing COVID-19 for people with cancer: A systematic review of the early evidence. , 33, DOI: https://doi.org/10.1016/j.jcpo.2022.100338.
Datasets shared by verified academics with rich metadata and previews.
Authors choose access levels; downloads are logged for transparency.
Students and faculty get instant access after verification.
Type
Article
Year
2022
Authors
22
Datasets
0
Total Files
0
Language
en
DOI
https://doi.org/10.1016/j.jcpo.2022.100338
Access datasets from 50,000+ researchers worldwide with institutional verification.
Get Free AccessYes. After verification, you can browse and download datasets at no cost. Some premium assets may require author approval.
Files are stored on encrypted storage. Access is restricted to verified users and all downloads are logged.
Yes, message the author after sign-up to request supplementary files or replication code.
Join 50,000+ researchers worldwide. Get instant access to peer-reviewed datasets, advanced analytics, and global collaboration tools.
✓ Immediate verification • ✓ Free institutional access • ✓ Global collaboration
